期刊文献+

表皮生长因子微球的制备与评价

The preparation and evaluation of EGF microsphere
暂未订购
导出
摘要 目的制备表皮生长因子(EGF)微球并对其生物学活性进行评价。方法利用改进的复乳法,以聚乳酸/羟基乙酸共聚物(PLGA)作为载体,制备EGF微球。检测EGF微球形貌表征、微球粒径分布、载药率、包封率和释药行为。用噻唑蓝(MTT)法测定增殖度,研究不同浓度EGF微球对细胞增殖能力的影响,研究相同浓度不同剂型EGF对细胞增殖的影响,研究微球载体的安全性。结果EGF微球粒径约为200nm,粒径分布比较均一,微球之间无粘连,分散性好。载药率为0.02%,包封率为85%。释药符合释放动力学模型,释放长达24h。不同浓度EGF微球均促进细胞增殖,其中10μg/L为最适质量浓度(与对照组比,P<0.01)。质量浓度10μg/L时,EGF微球组与EGF原液组相比差异有统计学意义(P<0.01)。不同质量浓度空微球对细胞没有毒性,不影响细胞增殖(组间没有差异,P>0.05)。结论成功制备EGF微球。细胞实验证明EGF微球制备过程中EGF保持原有活性,与EGF原液比较,EGF微球促进细胞增殖能力更强,微球载体对细胞没有毒性作用。 Objective To prepare epidermal growth factor(EGF) microsphere and evaluate its shape,particle diameter,drugloading efficiency, encapsulation ratio, release and biologic activity. Methods The modified multiple emulsion technique with polylactic-co-glycolic acid(PLGA) as carrier for preparing EGF microsphere was applied. The exosyndrome of EGF microsphere, diameter distribution,drug-loading efficiency, encapsulation ratio and release were determinened. The influence of cell proliferation with different concentration EGF microspheres was studied. The influence of cell proliferation with same concentration but different dosage form EGF was observed. The toxicity of particulate carrier for cell and influence on cell proliferation was researched. Results It was showed that the particle diameter of EGF microsphere was about 200 nm, particle diameter distribution was relative uniform, no conglutination among EGF microspheres, and dispersibility was good. The drugloading efficiency was 0.02 % ;encapsulation ratio was 85 %. The drug release behavior was coincided with Higuchi release kinetic model and lasted 24 hours. All of different concentration EGF microspheres could promote cell proliferation, but 10 μg/L was the optimal concentration (vs control group ,P 〈 0.01). The effects of different dosage form EGF with same concentration of 10 μg/L had difference. The EGF microsphere group was better than EGF stock solution group(P 〈 0.01). The different concentration empty microspheres showed no effect on cell proliferation (P 〉 0.05) and toxicity was not found. Conclusion The EGF microsphere is successfully prepared. It is demonstrated in cell experiment that EGF keeps good activity in EGF microsphere. The effect of EGF microsphere on promoting cell proliferation capacity is better than that of EGF stock solution. Toxic effect of particulate carrier on cells is not found.
出处 《生物医学工程与临床》 CAS 2009年第3期175-179,共5页 Biomedical Engineering and Clinical Medicine
关键词 表皮生长因子 微球制备 生物学活性 epidermal growth factor microsphere preparation biologic activity
  • 相关文献

参考文献14

  • 1Albert S.Cost-effective management of recalcitrant diabetic foot ulcers[J].Clin Podiatr Med Surg,2002,19(4):483-491.
  • 2Lobmann R,Schuhz G,Lehnert H.Molecular fundamentals of wound healing in diabetic foot syndrome[J].Med Klin (Munich),2003,98(5):292-301.
  • 3王世岭 孙同柱 周亮 等.rhEGF对皮片体外培养生长作用及其量效关系.中国药学杂志,1999,34(9):615-615.
  • 4Hori K,Sotozono C,Hamuro J,et al.Controlled-release of epidermal growth factor from cationized gelatin hydrogel enhances corneal epithelial wound healing[J].J Control Release,2007,118 (2):169-176.
  • 5Choi JS,Leong KW,Yoo HS.In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF)[J].Biomaterials,2008,29 (5):587-596.
  • 6许海燕.纳米技术在医学领域的应用研究[J].中华医学杂志,2006,86(8):505-506. 被引量:8
  • 7Jorgensen L Moeller EH,van de Wecrt M,et al.Preparing and evaluating delivery systems for proteins[J].Eur J Pharm Sci,2006,29(3-4):174-182.
  • 8Pinto Reis C,Neufeld R J,Ribeiro AJ,et al.Nanoencapsulation Ⅱ.Biomedical applications and current status of peptide and protein nanoparticulate delivery systems[J].Nanomedicine,2006,2(2):53-65.
  • 9Gelse K,Poschl E,Aigner T.Collagens-structure,function,and biosynthesis[J].Adv Drug Deliv Rev,2003,55(12):1531-1546.
  • 10附录XH重组人表皮细胞生长因子生物学活性测定法[S].中华人民共和国药典2005版三部.北京:化学工业出版社,2005.

二级参考文献9

  • 1Hughes GA.Nanostructure-mediated drug delivery.Dis Mon,2005,51:342-361.
  • 2Cancer Nanotechnology Plan.http://nano.cancer.gov.
  • 3Min BM,Lee G,Kim SH,et al.Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro.Biomaterials,2004,25:1289-1297.
  • 4Silva GA,Czeisler C,Niece KL,et al.Selective differentiation of neural progenitor cells by high-epitope density nanofibers.Science,2004,303:1352-1355.
  • 5Price RL,Waid MC,Haberstroh KM,et al.Selective bone cell adhesion on formulations containing carbon nanofibers.Biomaterials,2003,24:1877-1887.
  • 6McKenzie JL,Waid MC,Shi R,et al.Decreased functions of astrocytes on carbon nanofiber materials.Biomaterials,2004,25:1309-1317.
  • 7Service RF.Nanomaterials show signs of toxicity.Science,2003,300:5617.
  • 8Scientific Committee on Emerging and Newly-Identified Health Risks (SCENIHR).Opinion on The appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies.http://europa.eu.int/comm/health/ph_risk/committees/04.
  • 9Sandra S. Galoforo,Christine M. Berns,Geza Erdos,Peter M. Corry,Yong J. Lee. Hypoglycemia-induced AP-1 transcription factor and basic fibroblast growth factor gene expression in multidrug resistant human breast carcinoma MCF-7/ADR cells[J] 1996,Molecular and Cellular Biochemistry(2):163~171

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部